Infection Prevention Global Market Report 2024

The infection prevention market size has grown steadily in recent years. It will grow from $41.64 billion in 2023 to $43.4 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing awareness of healthcare-associated infections (HAIs), stringent regulatory guidelines, advancements in technology, globalization and international travel, and rising healthcare expenditure.

The infection prevention market size is expected to see steady growth in the next few years. It will grow to $50.21 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The forecasted growth in the upcoming period is driven by several factors, including the emergence of infectious diseases, technological advancements, global population growth, and an increase in ambulatory care services. Key trends anticipated during this period include the expansion of telemedicine and digital health solutions, the development of personalized infection prevention strategies, a greater reliance on artificial intelligence (AI), the use of rapid diagnostic tools, and a heightened focus on behavioral interventions.

The rise in hospital-acquired infections (HAIs) is expected to drive the growth of the infection prevention market. HAIs are infections that patients contract while receiving healthcare treatment in a hospital or other healthcare facility. Infection prevention strategies aim to reduce the risk of HAIs and improve patient safety. For example, according to the Australian Institute of Health and Welfare, hospitals reported 1,546 cases of Staphylococcus aureus bloodstream infections (SABSIs) in 2021-22, with a rate of 0.73 cases per 10,000 patient days. The increase in HAIs is a key factor propelling the growth of the infection prevention market.

Key players in the infection prevention market are innovating by developing new products such as infection preventionist staffing calculators to enhance their service offerings. These calculators help estimate the required number of infection preventionists in a healthcare facility based on factors such as bed count, patient acuity, and facility type. For example, the Association for Professionals in Infection Control and Epidemiology (APIC) launched an infection preventionist staffing calculator in December 2023. This tool aids hospitals and clinics in determining the appropriate number of infection preventionists (IPs) needed, thereby improving patient safety through optimal staffing levels. Continuous refinement of the calculator using data from healthcare facilities ensures accurate staffing recommendations.

In July 2021, Steris plc, an Ireland-based medical device company, completed the acquisition of Cantel Medical Corporation for $3.6 billion. This strategic move enhances Steris's infection prevention capabilities, expands its global footprint, and strengthens its customer base, particularly in the fields of endoscopy and dentistry. Cantel Medical Corporation, based in the US, is a renowned manufacturer of infection prevention and control products.

Major companies operating in the infection prevention market report are Cardinal Health Inc., 3M Company, Stryker Corporation, Reckitt Benckiser Group plc, Ecolab Inc., B. Braun Melsungen AG, The Clorox Company, Olympus Corporation, Fortive Corporation, Steris PLC, Genitge AB, Sotera Health Inc., Belimed AG, Coltene Group, Steelco S.p.A., Skytron LLC, Melag Medizintechnik GmbH & Co. KG, Metrex Research, Pal International, Cisa Production S.r.l. Unipersonale, Covalon Technologies Ltd., Biosafe Systems LLC, Terragene SA, Micro-Scientific LLC, Matachana SA.

North America was the largest region in the infection prevention market in 2023. The regions covered in the infection prevention market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infection prevention market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Infection prevention encompasses a range of measures and practices aimed at reducing the risk and spread of infectious diseases. These practices include hygiene measures such as regular hand washing, vaccination, and the use of protective equipment. They play a critical role in healthcare settings, public spaces, and personal care to safeguard both individual and public health.

The key product categories within infection prevention include sterilization equipment, disinfectors, and consumables. Sterilization equipment is used to eliminate all forms of microbial life, including bacteria, viruses, and spores, from surfaces, fluids, medications, or biological culture media. Various types of infections, including microbial and healthcare-associated infections, are targeted by these products. They are utilized by a range of end-users such as hospitals and clinics, pharmaceutical companies, clinical laboratories, medical device companies, the life science industry, and academic and research centers.

The infection prevention market research report is one of a series of new reports that provides infection prevention market statistics, including infection prevention industry global market size, regional shares, competitors with an infection prevention market share, detailed infection prevention market segments, market trends, and opportunities, and any further data you may need to thrive in the infection prevention industry. This infection prevention market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infection prevention market consists of revenues earned by entities by providing services such as disinfection, sterilization, and isolation precautions. The market value includes the value of related goods sold by the service provider or included within the service offering. The infection prevention market consists of sales of hand hygiene products, personal protective equipment (PPE), antimicrobial wipes and sprays, sharps disposal containers, and biohazard bags. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.